Jasmonates (JAs) are a family of plant hormones that regulate plant growth, development, and responses to stress. The F-box protein CORONATINE-INSENSITIVE 1 (COI1) mediates JA signaling by promoting hormone-dependent ubiquitination and degradation of transcriptional repressor JAZ proteins. Despite its importance, the mechanism of JA perception remains unclear. Here we present structural and pharmacological data to show that the true JA receptor is a complex of both COI1 and JAZ. COI1 contains an open pocket that recognizes the bioactive hormone, (3R,7S)-jasmonoyl-L-isoleucine (JA-Ile), with high specificity. High-affinity hormone binding requires a bipartite JAZ degron sequence consisting of a conserved α-helix for COI1 docking and a loop region to trap the hormone in its binding pocket. In addition, we identify a third critical component of the JA co-receptor complex, inositol pentakisphosphate, which interacts with both COI1 and JAZ adjacent to the ligand. Our results unravel the mechanism of JA perception and highlight the ability of F-box proteins to evolve as multi-component signaling hubs.
The flavoprotein cryptochromes (CRYs) act as blue-light receptors in plants and insects, but perform light-independent functions at the core of the mammalian circadian clock. To drive clock oscillations, mammalian CRYs associate with the Period proteins (PERs) and together inhibit the transcription of their own genes. The SCFFbxl3 ubiquitin ligase complex controls this negative feedback loop by promoting CRY ubiquitylation and degradation. Yet, the molecular mechanisms of their interactions and the functional role of flavin adenine dinucleotide (FAD) binding in CRYs remain poorly understood. Here we report crystal structures of mammalian CRY2 in its apo, FAD-bound, and Fbxl3-Skp1-complexed forms. Distinct from other cryptochromes of known structures, mammalian CRY2 binds FAD dynamically with an open cofactor pocket. Strikingly, the F-box protein Fbxl3 captures CRY2 by simultaneously occupying its FAD-binding pocket with a conserved C-terminal tail and burying its PER-binding interface. This novel F-box protein-substrate bipartite interaction is susceptible to disruption by both FAD and PERs, suggesting a new avenue for pharmacological targeting of the complex and a multifaceted regulatory mechanism of CRY ubiquitylation.
Nitrate is a primary nutrient for plant growth, but its levels in soil can fluctuate by several orders of magnitude. Previous studies have identified Arabidopsis NRT1.1 as a dual-affinity nitrate transporter, which can take up nitrate over a wide range of concentrations. The mode of action of NRT1.1 is controlled by phosphorylation of a key residue, Thr101. Yet how this posttranslational modification switches the transporter between two affinity states remains unclear. Here we report the crystal structure of unphosphorylated NRT1.1, which reveals an unexpected homodimer in the inward-facing conformation. In this low-affinity state, the Thr101 phosphorylation site is embedded in a pocket immediately adjacent to the dimer interface, linking the phosphorylation status of the transporter to its oligomeric state. Using a cell-based fluorescence resonance energy transfer assay, we show that functional NRT1.1 indeed dimerizes in the cell membrane and the phosphomimetic mutation of Thr101 converts the protein into a monophasic high affinity transporter by structurally decoupling the dimer. Together with analyses of the substrate transport tunnel, our results establish a phosphorylation-controlled dimerization switch that allows NRT1.1 to uptake nitrate with two distinct affinity modes.
Protein poly(ADP-ribosyl)ation and ubiquitination are two key post-translational modifications regulating many biological processes. Through crystallographic and biochemical analysis, we show that the RNF146 WWE domain recognizes poly(ADP-ribose) (PAR) by interacting with iso-ADP-ribose (iso-ADPR), the smallest internal PAR structural unit containing the characteristic ribose-ribose glycosidic bond formed during poly(ADP-ribosyl)ation. The key iso-ADPR-binding residues we identified are highly conserved among WWE domains. Binding assays further demonstrate that PAR binding is a common function for the WWE domain family. Since many WWE domain-containing proteins are known E3 ubiquitin ligases, our results suggest that protein poly(ADP-ribosyl)ation may be a general mechanism to target proteins for ubiquitination.Supplemental material is available for this article.Received November 2, 2011; revised version accepted December 19, 2011. Protein ubiquitination regulates diverse biological processes; however, the mechanism by which proteins are earmarked for ubiquitination remains incompletely understood. Other than phosphorylation, which is a general mechanism for many cases, hydroxylation of a substrate (i.e., HIF1-a) and the binding of small molecules (e.g., the plant hormone auxin) to E3 ligases have been shown to control protein ubiquitination in sporadic cases (Willems et al. 1999;Min et al. 2002;Bergink and Most recently, PARylation has been shown to control the polyubiquitination and degradation of axin, a key regulator of the Wnt signaling pathway (Huang et al. 2009;Callow et al. 2011;Kang et al. 2011;Zhang et al. 2011). In all of these reports, RNF146 (aka Iduna), which contains a WWE domain and a RING domain (Supplemental Fig. 1), is the only known E3 ubiquitin ligase to date that requires PARylation of the substrate for subsequent polyubiquitination (Callow et al. 2011;Kang et al. 2011;Zhang et al. 2011). The RNF146 WWE domain has been shown to bind PAR (Callow et al. 2011;Zhang et al. 2011), and it was reported that a short PAR-binding motif (PBM) within the domain retains this binding activity ). The PBM was originally found in histones and several other proteins (Gagne et al. 2008). However, the PBM identified in RNF146 is not conserved in other WWE domains, so it remains unclear whether the WWE domain represents a novel PAR-binding domain. Here we reveal the structural basis of the RNF146 WWE domain/iso-ADPR interaction and, for the first time, define the PAR/iso-ADPR binding as a bona fide function of the WWE domain family. Importantly, the structural coupling of WWE domains and E3 ligase domains in many WWE domaincontaining proteins suggests a functional coupling of protein PARylation and ubiquitination. Results and DiscussionThe RNF146 WWE domain recognizes iso-ADPR, but not ADPR We sought to clarify the requirement of the entire RNF146 WWE domain structure for PAR binding through structural analysis. PAR polymers display high chemical heterogeneity (in both lengths and branching patterns) and ar...
The canonical Wnt pathway plays critical roles in embryonic development, stem cell growth, and tumorigenesis. Stimulation of the Wnt pathway leads to the association of beta-catenin with Tcf and BCL9 in the nucleus, resulting in the transactivation of Wnt target genes. We have determined the crystal structure of a beta-catenin/BCL9/Tcf-4 triple complex at 2.6 A resolution. Our studies reveal that the beta-catenin binding site of BCL9 is distinct from that of most other beta-catenin partners and forms a good target for developing drugs that block canonical Wnt/beta-catenin signaling. The BCL9 beta-catenin binding domain (CBD) forms an alpha helix that binds to the first armadillo repeat of beta-catenin, which can be mutated to prevent beta-catenin binding to BCL9 without affecting cadherin or alpha-catenin binding. We also demonstrate that beta-catenin Y142 phosphorylation, which has been proposed to regulate BCL9-2 binding, does not directly affect the interaction of beta-catenin with either BCL9 or BCL9-2.
The tumor suppressor adenomatous polyposis coli (APC) plays a critical role in the turnover of cytosolic beta-catenin, the key effector of the canonical Wnt signaling pathway. APC contains seven 20 amino acid (20 aa) beta-catenin binding repeats that are required for beta-catenin turnover. We have determined the crystal structure of beta-catenin in complex with a phosphorylated APC fragment containing two 20 aa repeats. Surprisingly, one single phosphorylated 20 aa repeat, together with its flanking regions, covers the entire structural groove of beta-catenin and may thus compete for beta-catenin binding with all other beta-catenin armadillo repeat partners. Our biochemical studies show that phosphorylation of the APC 20 aa repeats increases the affinity of the repeats for beta-catenin by 300- to 500-fold and the phosphorylated 20 aa repeats prevent beta-catenin binding to Tcf. Our work suggests that the phosphorylation of the APC 20 aa repeats could be a critical switch for APC function.
SUMMARY The plant hormone strigolactones (SLs) regulate many aspects of plant physiology. In shoot branching inhibition, the SL-metabolizing α/β hydrolase D14 interacts with the F-box protein D3 to ubiquitinate and degrade the transcription repressor D53. Despite multiple modes of D14-SL interactions determined recently, how the hydrolase functions with D3 to mediate hormone-dependent D53 ubiquitination remains elusive. Here we show that D3 features a C-terminal α-helix (CTH), which can switch between two conformational states. Distinct from its engaged form, which facilitate the binding of D3 and D14 with a hydrolyzed SL intermediate, the dislodged D3 CTH can recognize unmodified D14 in an open conformation and inhibits its enzymatic activity. In an SL-dependent manner, the D3 CTH enables D14 to recruit D53, which in turn activates the hydrolase. By unraveling an unexpected structural plasticity in SCF D3-D14 ubiquitin ligase, our results suggest an intricate mechanism by which the E3 coordinates SL signaling and metabolism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.